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Abstract
Background: Nonesterified fatty acids (NEFAs) are involved in proinflammatory processes in cattle, including in the
increased expression of adhesion molecules in endothelial cells. However, the mechanisms underlying these effects
are still unknown. The aim of this study was to assess the effects of NEFAs on the intracellular calcium (Ca2+i) influx,
nitric oxide production, and ICAM-1 and IL-8 expression in primary bovine umbilical vein endothelial cells (BUVECs).
Results: Myristic (MA), palmitic (PA), stearic (SA), oleic (OA) and linoleic acid (LA) rapidly increased Ca2+i. The
calcium response to all tested NEFAs showed an extracellular calcium dependence and only the LA response was
significantly inhibited until the intracellular calcium was chelated. The EC50 values for MA and LA were 125 μM and
37 μM, respectively, and the MA and LA effects were dependent on calcium release from the endoplasmic
reticulum stores and on the L-type calcium channels. Only the calcium response to MA was significantly reduced
by GW1100, a selective G-protein-coupled free fatty acid receptor (GPR40) antagonist. We also detected a functional
FFAR1/GPR40 protein in BUVECs by using western blotting and the FFAR1/GPR40 agonist TAK-875. Only LA
increased the cellular nitric oxide levels in a calcium-dependent manner. LA stimulation but not MA stimulation
increased ICAM-1 and IL-8-expression in BUVECs. This effect was inhibited by GW1100, an antagonist of FFAR1/
GPR40, but not by U-73122, a phospholipase C inhibitor.
Conclusions: These findings strongly suggest that each individual NEFA stimulates endothelial cells in a different way,
with clearly different effects on intracellular calcium mobilization, NO production, and IL-8 and ICAM-1 expression in
primary BUVECs. These findings not only extend our understanding of NEFA-mediated diseases in ruminants, but also
provide new insight into the different molecular mechanisms involved during endothelial cell activation by NEFAs.
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Background
The levels of nonesterified fatty acids (NEFAs) in bovine
plasma increase during transition periods, such as after
calving and during early lactation [1]. During these stages,
a negative energy balance is generated, which is mainly
characterized by an increased release of NEFAs from adi-
pose tissues into the plasma [2]. Elevated plasma NEFA
concentrations have recently been related to the incidence
of metabolic and infectious bovine diseases, including fatty
hepatitis, metabolic ketosis, mastitis, and endometritis,
which cause high economic losses to the cattle industry
worldwide [2, 3]. Therefore, NEFAs directly affect tissue/
organ functions, and even more importantly, indirectly
affect the bovine innate immune system, as previously re-
ported [4].
Endothelial cells are highly immunoreactive cells that
synthesize a broad spectrum of chemokines, cytokines,
and adhesion molecules, and therefore play an active
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part in early proinflammatory reactions [5]. Consistent
with this, the exposure of primary bovine aortic endo-
thelial cells (BAECs) to a mixture of NEFAs for 24 h al-
tered their membrane phospholipid profile, increasing
the stearic acid concentration and reducing the polyun-
saturated fatty acid concentrations [6]. In the same
study, 0.75 mM NEFA increased the expression of the
proinflammatory cytokines interleukin 6 (IL-6) and IL-8,
and the adhesion molecules intercellular adhesion mol-
ecule 1 (ICAM-1) and vascular cell adhesion molecule 1
(VCAM-1) in BAECs [6], which interact with other im-
munocompetent cells, such as neutrophils. Although the
effects of NEFAs on bovine leukocytes and endothelial
cells have been examined previously [1, 7, 8], the exact
molecular mechanisms are still poorly understood.
It has long been accepted that the hydrophobic nature
of lipids allows them to activate cells after they enter
them, e.g., through membrane transport mechanisms
[9, 10]. However, a G-protein-coupled free fatty acid re-
ceptor known as GPR40 or free fatty acid receptor 1
(FFAR1) has recently been described [11]. This novel free
fatty acid receptor recognizes saturated and unsaturated
medium- and long-chain fatty acids, and the human, rat,
and mouse isoforms of FFAR1/GPR40 have been de-
scribed [11, 12]. Recently, the effects of FFAR1/GPR40 ag-
onists, such as oleic acid (OA) and linoleic acid (LA), have
been demonstrated in epithelial mammary cells [13] and
neutrophils [14, 15]. Consequently, primary bovine tissues
are thought to be susceptible to NEFA exposure primarily
via the corresponding bovine free fatty acid receptor 1
(bFFA1R/bGPR40). Based on this evidence, we evaluated
whether different types of NEFAs can rapidly modify the
intracellular calcium response in primary bovine endothe-
lial cells exposed to single fatty acids and to study in more
detail the molecular mechanisms involved in this endothe-
lial activation.
Results
Acute treatment with NEFAs does not affect the viability of
primary bovine umbilical vein endothelial cells (BUVECs)
Cells exposed to 300 μM LA, palmitic acid (PA), OA, myr-
istic acid (MA), or stearic acid (SA) showed no significant
difference in the propidium iodide signal for 15 min when
compared with untreated cells (basal condition) (see
Additional file 1). Similar results were observed in
BUVECs exposed to 1 % vehicle (DMSO or ethanol) for
the same period. Therefore, exposure to 300 μM of each
fatty acid did not increase BUVEC death any more than
Triton X-100 treatment, used as the positive control. We
demonstrated that 0.3 mM EGTA, 50 μM BAPTA-AM or
each NEFA plus EGTA or BAPTA did not affect the via-
bility of BUVECs (see Additional file 1). These results
clearly demonstrate that these fatty acid concentrations
and exposure time have no toxic effects on BUVECs.
NEFAs increase the intracellular calcium influx in BUVECs
The intracellular calcium response in primary bovine
endothelial cells was evaluated in BUVECs exposed
acutely to different NEFAs for 100 s. The calcium signal
increased quickly after stimulation with 300 μM MA,
PA, SA, or OA, with similar kinetics, and the intracellu-
lar calcium levels reached a new steady state (Fig. 1a–d,
black traces). In contrast, LA caused a slow but constant
increase in intracellular calcium (Fig. 1e). To identify the
roles of intracellular and extracellular calcium, we used
the well-known calcium-chelating agents BAPTA-AM
and EGTA. Incubation with BAPTA-AM reduced the
slope of calcium increase by more than 50 % in all cases,
except for LA (see Additional file 2). However, this did
not affect the area under the curve (AUC) of calcium
flux (Fig. 1f–i). Moreover, the BAPTA-AM treatment
significantly reduced the area under the curve (AUC)
only in cells previously exposed to LA (Fig. 1j). The lat-
ter suggests that the increase in calcium induced by LA
is dependent on intracellular and extracellular calcium
mobilization. In our experiments, the NEFA-mediated
increase in calcium was significantly inhibited in the
presence of EGTA (as illustrated in Fig. 1a–e, light gray
traces; Fig. 1f–j), suggesting that the increase in calcium
in the whole experiment is mainly depended on calcium
influx.
Mechanisms of MA and LA effects on intracellular calcium
release in BUVECs
We investigated the potential differential responses of
BUVECs to MA and LA, exemplary for saturated and
unsaturated NEFAs, respectively. To investigate the mech-
anism of the calcium increase, we first constructed dose–
response curves of the calcium signal after stimulation
with MA and LA, and obtained half-maximal effective
concentrations (EC50) of 125 and 37 μM, respectively
(Fig. 2a, d). We then used concentrations close to the
EC50 values to assess the mechanisms involved in calcium
flux. Upon stimulation with 100 μM MA, BUVECs
showed a rapid increase in calcium, which decreased until
a new steady state was reached after 30 s (Fig. 2b, inset).
In contrast, stimulation with 30 μM LA caused a sus-
tained increase in calcium within the first 100 s (see
Fig. 2e, inset), and a steady state was observed after stimu-
lation for 200 s (data not shown).
To evaluate whether FFAR1/GPR40 actively partici-
pates in the calcium increase induced by MA or LA, we
used its antagonist GW1100, as previously reported [16].
The response produced by 100 μM MA was inhibited by
59 % by 10 μM GW1100 (see Fig. 2c). This was also ob-
served when other saturated fatty acids were used in our
in vitro bovine endothelial cell system, and GW1100
inhibited 66 and 63 % of the calcium response induced by
300 μM PA and SA, respectively (see Additional file 3). In
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contrast, the calcium influx response to 30 μM LA was
not affected by GW1100 (Fig. 2f), and a similar response
was observed when OA was used as the unsaturated fatty
acid (see Additional file 3).
To assess the role of the G-protein Gαi/o, phospholip-
ase C (PLC), and the inositol triphosphate (IP3) recep-
tors/calcium-operated channels induced by MA and LA,
we used pertussis toxin (PTX) [17], U73122 [18], and 2-
APB [19–21], respectively. We demonstrated that prein-
cubation with 100 ng/ml PTX for 16 h did not inhibit
the calcium influx induced either by MA or LA fatty
acids in BUVECs, which suggests that Gαi/o does not
participate in this type of response. The mobilization of
calcium by LA was reduced by 4 μM U73122, but the ef-
fect of MA was not affected by treatment with the PLC
inhibitor. 2-APB (100 μM) reduced both the MA- and
LA-mediated increases in calcium by 25 and 23 %, re-
spectively (see Fig. 2c and f).
There is some evidence that fatty acids can directly
and indirectly activate the L-type calcium channels
(LTCCs) in HEK293, COS-7 and rat insulinoma INS-1E
cells in vitro [22, 23]. However, the participation of
LTCCs in the calcium increase induced by MA or LA in
BUVECs has not been evaluated. Therefore, we investi-
gated whether these channels participate in the calcium
increase induced by MA or LA stimulation. Our results
show that the LTCC blocker nifedipine (20 μM) inhib-
ited the increases in calcium induced by MA and LA by
45 and 22 %, respectively (Fig. 2c and f). These results
suggest that LTCCs participate in the increases in cal-
cium caused by saturated and unsaturated fatty acids in
BUVECs.
FFAR1/GPR40 expression and activity
To examine FFAR1/GPR40 protein expression in BUVECs,
we used western blotting and immunofluorescence assays
directed against the conserved epitope of bovine GPR40,
as described elsewhere [14]. An immunoblotting analysis
of the total protein extracts of BUVECs showed a band
with an apparent molecular size of 23-kDa, lower than ex-
pected but similar to that observed in LoVo cells, which
were used as the positive control, as suggested by the
manufacturer of the anti-GPR40 antibody (Fig. 3a). The
same antibody was used for the immunofluorescence as-
says of BUVECs, which detect the internal region of hu-
man GPR40, and therefore the intracellular and plasma
membrane distribution (Fig. 3b). To confirm that the
FFAR1/GPR40 protein is in its active form in BUVECs, we
also measured the calcium signal separately with two known
FFAR1/GPR40 agonists, TAK-875 [24] and GW9508 [16].
TAK-875 increased the intracellular calcium in a dose-
dependent manner (Fig. 3c, d), whereas GW9508 did not
change the calcium signal at either low (10, 50 μM) or
high concentrations (100 μM; data not shown).
LA increases nitric oxide (NO) production
To assess whether NEFAs affect NO production in the
endothelium, we exposed BUVECs to MA, SA, PA, OA,
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Fig. 1 Intracellular calcium increases caused by NEFAs are dependent on extracellular calcium. a–e Time courses of representative Fura-2 ratio
signals in at least three assays, caused by 300 μM of each NEFA in BUVEC cells. Each NEFA was added at 50 s during a 100 s period (black line).
Suspended cells were exposed to each NEFA in HBSS, without or with pretreatment with 50 μM BAPTA-AM or calcium-free HBSS/0.3 mM EGTA
(black, dark grey, and light grey traces, respectively). Before fatty acid exposure, EGTA was added at the light grey arrow. BUVECs were also exposed
to only to the vehicle control at 50 s (dotted traces). Ethanol (1 %) was used as the vehicle for MA and SA. DMSO (1 %) was used as the vehicle
for PA, OA, and LA. f–j AUCs for NEFAs in HBS buffer (black bars), calcium-free buffer with 0.3 mM EGTA (light grey bars), or after BAPTA treatment
(dark grey bars). AUC of vehicle alone, 1 % ethanol or 1 % DMSO (white bars). The data are expressed as the means ± SEM of at least three
experiments. *p < 0.05, **p < 0.01, ***p < 0.005
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or LA and evaluated the cells for NO production using
DAF-FM signals. Only LA significantly increased the
DAF-FM fluorescence intensity in BUVEC monolayers.
As illustrated in Fig. 4a, the DAF-FM signal increased ap-
proximately 1.5-fold in LA-exposed BUVECs compared
with the signal in cells treated with vehicle (DMSO). The
increase in NO induced by LA was reduced by 25 % when
the cells were treated with 100 μM L-NAME, a potent
endothelial nitric oxide synthase (eNOS) inhibitor (Fig. 4c).
This indicates that LA activates eNOS in primary bovine
endothelial cells. Treatment with BAPTA, EGTA, or
BAPTA plus EGTA reduced the increase in NO induced
by LA by 50, 91, and 86 %, respectively (Fig. 4b). In con-
trast, neither 4 μM U73122, 10 μM GW1100, 100 μM 2-
APB, 20 μM nifedipine, nor 100 ng/ml PTX reduced the
LA-mediated increase in NO (data not shown).
LA but not MA increases ICAM-1 and IL-8 mRNA
expression
Because only LA effectively increased eNOS activity in
BUVECs, we tested whether LA also affects ICAM-1 or
IL-8 expression. Only LA induced the expression of
ICAM-1 and IL-8 mRNAs in BUVECs, and LA-induced
IL-8 expression was significantly inhibited by GW1100.
However, the expression of ICAM-1 was not reduced by
treatment with the FFAR1/GPR40 antagonist (Fig. 5).
Discussion
The NEFA levels in blood plasma are particularly ele-
vated during the transition period in dairy cattle, when
lipids are strongly mobilized from the adipose tissues to
the bloodstream, with plasma concentrations increasing
from the basal level of 0.1 mM to 0.7–2 mM [1, 25–27].
Until now, the involvement of G-coupled fatty acid re-
ceptors, such as FFAR1/GPR40, in the NEFA-mediated
calcium response in primary endothelial cells has been
unclear. This study has demonstrated that single NEFAs
alone, at low concentrations of 0.3 mM, increase the
intracellular calcium response in primary bovine endothe-
lial cells, inducing different molecular pathways involved
in the endothelial cell activation process. In naturally oc-
curring acute systemic coliform mastitis linoleic acid and
oleic acid were the most abundant NEFA, suggesting that
specific fatty acids can be involved in inflammation and
innate immunity, and to be relevant as risk factors during

































































































Fig. 2 Signaling routes of the calcium responses caused by MA and LA in BUVECs. a and d Dose–response of calcium signaling induced by
myristic acid (MA) or linoleic acid (LA). The area under the curve (AUC) calculated for the first 100 s of the Fura-2/AM time course. b and e Average
time courses for the Fura-2 ratio in BUVECs exposed to 100 μM MA in ethanol or 30 μM LA in 1 % DMSO. Graph inset: whole time course of the
Fura-2/AM ratio after exposure to 100 μM MA before the addition of 132 μM digitonin (dig) (representative assay). c and f Calcium response in cells
triggered by 1 % ethanol or 1 % DMSO, 100 μM MA or 30 μM LA alone or after preincubation with 100 μM 2-APB, 10 μM GW1100, 4 μM U73122 (U7),
or 20 μM nifedipine (NIFE) for 15 min. Cells were incubated for 16 h with 100 ng/ml pertussis toxin (PTX) before MA or LA supplementation. The data
are expressed as the means ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.005
Loaiza et al. BMC Veterinary Research  (2016) 12:38 Page 4 of 11
Different studies have reported the potency with which
MA and LA bind to human FFAR1/GPR40 in trans-
fected CHO and HEK293 cells by measuring the calcium
signal. For MA, a EC50 value has been described in these
cells, close to 7 μM, but for LA, the EC50 values ranged
from 1.8 to 6.6 μM [11, 12]. In contrast, the EC50 values
for MA and LA were 30.3 and 38.4 μM, respectively, in
a reporter cell line based on HeLa cells transfected with
hGPR40 [29]. These results are quite similar to those ob-
served in the present study, especially regarding the
stimulatory potency of LA. Because many of the effects
of NEFAs on primary bovine endothelial cells could be
attributed to bGPR40, including increased intracellular
calcium influx, the presence of this specific NEFA recep-
tor was assessed in BUVECs in this study. We detected
FFAR1/GPR40 expression in BUVECs, and also evalu-
ated its effect on the calcium flux using the agonist
TAK-875 in our in vitro primary bovine endothelial cell
system. There is some evidence that FFAR1/GPR40 is
expressed in bovine cells and bovine FFAR1/GPR40 has
been shown to share 84 % nucleotide sequence identity
with the human isoform [13, 14]. Previous studies have
examined the expression of GPR40 in endothelial cells
from monkey brain tissues [30], neuromicrovascular
cells from rodent tissues [31], and human cardiac endo-
thelial cells [32]. To the best of our knowledge, this work
is the first to report the expression of GPR40 in primary
bovine endothelial cells.
Our data also suggest that the MA-mediated increase
in calcium occurs when MA binds to bGPR40, because
it was clearly inhibited by GW1100, a potent FFAR1/
GPR40 antagonist. In contrast, the increase in calcium
induced by LA does not involve this receptor, according
to our antagonist experiments. We also observed that
IP3 receptors/calcium-operated channels and LTCCs
seem to participate in the cellular responses to MA and
LA, respectively. Others have shown, that OA increased
the calcium signal in HEK 293 cells transiently trans-
fected with the α1 subunits of the LTCCs [23]. The path-
way of calcium entry via the LTCCs induced by NEFAs
is evidently cell-type dependent. LTCCs were also associ-
ated with the increase in calcium mediated by FFAR1/
GPR40 activation that was induced by the saturated fatty
acid PA in rat β-cell line INS-1E [22], by the unsaturated
fatty acid OA in islet β-cells from rats [33], and by LA
in primary cultured chicken hepatocytes [34]. Our exam-
ination of the cellular calcium flux suggests that MA,
but not LA, recognizes FFAR1/GPR40 in BUVECs. The
CACNA2D1 gene encodes the alpha 2/delta subunit
which is an accessory part of the voltage-gated calcium
channel family (e.g., LTCC) and considered to be an im-
portant candidate protein influencing bovine mastitis
A B
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Fig. 3 Protein expression and functional detection of FFAR1/GPR40 in BUVEC monolayers. a Western blot of bovine FFAR1/GPR40. Total protein
extract from LoVo cells was used as the positive control for two BUVEC isolates. 50 μg of total protein was loaded onto a 6 % polyacrylamide gel.
b FFAR1/GPR40 immunofluorescence. Left image, nuclear signals of cells incubated with propidium iodide (PI); inset image: only the secondary
antibody was used, as the negative control, bar = 20 μm. Middle image, FFAR1/GPR40 detected with rabbit anti-GPR40 antiserum and an anti-
rabbit IgG secondary antibody. Right image, nuclear signals and GPR40 images are superimposed, bar = 20 nm. c Representative time course of
the Fura-2/AM ratio in BUVECs exposed to 1 % DMSO or 100 μM TAK-875 at the time indicated by the arrow. d Cells were exposed to DMSO or
TAK-875. The area under the curve (AUC) was calculated during the first 100 s after exposure to the stimulus. The data are expressed as the
means ± SEM of at least three independent experiments. **p < 0.01, ***p < 0.005
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[35]. Although many publications have reported LTCC
activity in bovine immune cells, there is not yet any evi-
dence that these channels are expressed in bovine endo-
thelial cells. In the present study, nifedipine affected
BUVECs, suggesting the participation of LTCCs. It has
also been recently demonstrated that the increase in cal-
cium caused by endothelin-1 is LTCC-dependent in cul-
tured bovine corneal endothelial cells [36].
We also evaluated the NO response in NEFA-exposed
bovine endothelium, because NO is a well-known indi-
cator of inflammation [37]. All NEFAs were evaluated,
but only LA increased NO in the endothelial cells. This
response was dependent on both calcium and eNOS.
There is evidence that eNOS activity is dependent on
Ca2+/calmodulin [38], and it is probable that the in-
crease in NO is a secondary effect after the interaction
of eNOS with Ca+2/calmodulin. Both NO and eNOS ac-
tively participate in the regulation of vascular tone and
are therefore important intracellular enzymes, especially
in microvascular hyperpermeability [39]. There is some
evidence that increased levels of NO in endothelial cells
produce proinflammatory profiles, which might lead to
metabolic diseases. LA induces reactive oxygen species
(ROS) and the overproduction of NO after an increase
in calcium, causing peroxynitration in endothelial cells
[40]. NF-κB, a crucial transcription factor, is then acti-
vated by peroxynitrite, a potent oxidative agent, inducing
the expression of adhesion molecules [40] and chemo-
kines, such as IL-8 [41]. We also demonstrated that LA,
but not MA, induces ICAM-1- and IL-8-expression,
suggesting an active role for NO in this response. In bo-
vine endothelial cell cultures, high concentrations of
total NEFAs might increase ICAM-1 mRNA and protein
expression [6]. The LA-induced adhesion molecules and
chemokines may participate in leukocyte-endothelial cell
interactions, facilitating transendothelial migration [42],
and may play a role in the onset of a proinflammatory
process during the transition period in dairy cattle.
Massive lipid mobilization leading to an increase in
plasma NEFAs is observed in cows around parturition,
causing an increased incidence of metabolic and infectious
diseases, including laminitis, endometritis, and mastitis







































Fig. 4 NEFA effects on nitric oxide production in BUVECs. a Basal DAF fluorescence (−), and after treatment with 0.1 % ethanol, 300 μM myristic
acid (MA), 300 μM stearic acid (SA), 0.1 % DMSO (D), 300 μM palmitic acid (PA), 300 μM oleic acid (OA), or 300 μM linoleic acid (LA) for 5 min at
37 °C. b DAF fluorescent signal after incubation with 300 μM LA for 5 min, normalized to the signal without fatty acids. The cells were incubated
with BAPTA, EGTA, or BAPTA + EGTA before treatment with LA. c Effect of L-NAME and GW1100 on the LA-induced increase in the DAF signal.
Basal fluorescence. DAF fluorescence is expressed in arbitrary units (a.u.). Each bar represents the mean ± SEM of at least three independent experiments.
*p < 0.05, **p< 0.01, ***p< 0.005
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[1–4]. The exposure of bovine endothelial cells to NEFAs
increases the expression of the proinflammatory cytokines
IL-6 and IL-8 and the adhesion molecules ICAM-1 and
VCAM-1 [6]. It has also been postulated that the excessive
accumulation of NEFAs during chronic inflammatory re-
sponses might increase TNFα, IL-6, and IL-1β expression
by activating NF-κB in adipocytes and macrophages.
These cytokines are thought to link the metabolic state
and the inflammatory response, usually in the postpartum
period within the uteri of cows [3, 4].
There is evidence that endothelial calcium participates
in the transendothelial lymphocyte migration caused by
ICAM-1 [43]. Moreover, an intracellular calcium in-
crease has been related with ICAM-1 expression in
HUVEC [44]. However, in BUVECs, intracellular cal-
cium increase could be not directly associated with the
expression of ICAM-1 or IL-8. Consistently with these
assumption MA increased calcium flux was not suffi-
cient to increase the expression of these molecules and
the inhibition of PLC did not reduce the expression of
ICAM-1 and IL-8 induced by LA. Our data also demon-
strate that the individual NEFAs have different effects on
endothelial cell activity and diverse mechanisms of ac-
tion. LA induces the expression of ICAM-1 independ-
ently of FFAR1/GPR40 or PLC activity, although the
expression of IL-8 is associated with the activation of
FFAR1/GPR40 in BUVECs. In contrast, our results
showed that NO was induced by LA, in a rather G-
protein-coupled-receptor-independent process. There is
some evidence that these receptors need not bind to a
G-protein in the presence of high agonist concentra-
tions, which thereby alternatively activate the ERK/
MAPK pathway [45]. It has been suggested that LA acti-
vates the phosphoinositide 3-kinase, ERK1/2, and p-38
MAPK pathways in vascular endothelial cells [46]. In
our laboratory, we have recently shown that the increase
in NO caused by LA is p38-dependent (unpublished
data). For this reason, it is possible that LA activates
FFAR1/GPR40 or another receptor in a G-protein-
independent manner. For instance, we cannot exclude
the possibility that the GPR120 receptor recognizes LA
by another mechanism [16, 47], or that LA is recognized
by GPR84, a medium-chain fatty acid receptor [48], or
CD36, a fatty acid transporter protein [49, 50]. Only
CD36 expression has been demonstrated in endothelial
cells [51]. It has also been proposed that LA mobilizes
intracellular calcium via an LA metabolite that induces
intracellular mitochondrial calcium fluxes [52].
Conclusions
We have demonstrated for the first time in primary bo-
vine endothelial cells that GPR40 is involved in the in-
crease in calcium induced by MA, and conversely, that
the LA calcium flux is not associated with this receptor.
We have also demonstrated the participation of IP3 re-
ceptors/calcium-operated channels and LTCCs in the
cellular responses to MA and LA. We observed FFAR1/
GPR40 expression in the bovine endothelium and con-
firmed its activity using its agonist, TAK-875. Only LA
increased NO levels, and this was independent of
FFAR1/GPR40. Only LA induced the expression of
ICAM-1 and IL-8, and this phenomenon is a FFAR1/
GPR40- dependent cellular process. These results indi-
cate that the responses of endothelial cells to individual
NEFAs are highly variable. Recently, it has been demon-
strated that there is an association of LA enhancement
in plasma and milk in naturally occurring acute systemic
coliform mastitis [52]. Therefore, the increase in total
NEFAs that is described as risk factor for the onset of pro-
inflammatory process that occur during transition periods
in cattle, should be revised carefully in the future. Further
studies are required to determine whether other individ-
ual NEFAs participate in the bovine proinflammatory
Fig. 5 NEFA effects on ICAM-1 and IL-8 expression in BUVECs. Cells
were treated with 0.1 % ethanol, 300 μM myristic acid (MA), 0.1 %
DMSO, 300 μM oleic acid (OA), or 300 μM linoleic acid (LA) for 3 h
and their RNAs were then isolated. Some cells were treated with
10 μM GW1100 or 4 μM U73122 (U-73) for 30 min before the LA
treatment. The expression of ICAM-1 and IL-8 was analyzed with
real-time PCR using specific primers. Relative abundance = 2–ΔCt,
where ΔCt = cycle treshold ICAM-1 or Ct IL-8 minus cycle treshold
SDHA. The data are expressed as the means ± SEM of three
experiments. *p < 0.05
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responses in vivo during the transition period and in
other NEFA-dependent disorders in cattle.
Methods
Fatty acids
We used those fatty acids that have shown changes dur-
ing transition period [1]. Myristic and stearic acids were
purchased from Sigma Chemical Co. (St. Louis, MO,
USA) and suspended in 100 % analytical-grade ethanol
(Merck, Germany). Palmitic, oleic, and linoleic acids
(Sigma Chemical Co. USA) were prepared in 100 %
DMSO (Sigma Chemical Co. USA). Stocks of single fatty
acids were prepared at concentrations of 300 mM, pro-
tected from light, and stored at −20 °C. To estimate the
calcium dose responses, the fatty acids were diluted to
the indicated concentrations, with the vehicle main-
tained at 1 % DMSO or 1 % ethanol to avoid a possible
dilution effect of vehicles. Because 300 μM concentra-
tions of all fatty acids were used in the NO experiments,
0.1 % DMSO or 0.1 % ethanol were used as the vehicles.
Neither the DMSO nor ethanol concentration used for
the calcium and NO assays affected the viability of
BUVECs during period of exposure. The working stocks
of fatty acids were maintained at 37 °C and were pro-
tected from light before to use.
Cell culture
Primary BUVECs were isolated from bovine umbilical
cords according to Hermosilla et al. [53]. All bovine um-
bilical cords were obtained as part of natural parturition
procedures at the Clinic for Obstetrics and Gynaecology
and Andrology of Large and Small animals, Faculty of
Veterinary Medicine, Justus Liebig University Giessen,
Germany therefore no intervention was made or ethic
approval was requested.
Briefly, the umbilical veins were isolated from the um-
bilical cords of calves born by cesarean section and kept
at 4 °C in sterile 0.9 % Hanks balanced salt solution
HBSS–HEPES buffer (w/v; pH 7.4; Gibco, USA) supple-
mented with 1 % penicillin (v/v; 500 U/ml) and strepto-
mycin (v/v; 500 μg/ml, Sigma-Aldrich) until use. Under
sterile conditions, one end of each umbilical cord vein
was clamped shut, and 0.025 % collagenase type II (w/v;
Worthington Biochemicals Corporation, USA) in Puck’s
saline A solution (PSA; Gibco, USA) was gently infused
into the vein lumens. After the remaining open ends of
the umbilical veins were clamped, they were incubated
at 37 °C in 5 % CO2 for 20 min. The umbilical veins
were then gently massaged and unclamped, and the
resulting collagenase solutions were collected individu-
ally in 50 ml plastic tubes (Nunc, USA) containing 1 ml
of fetal calf serum (FCS; Gibco) to inactivate the collage-
nase. The umbilical vein lumens were then washed twice
with RPMI 1640 culture medium (Gibco). The washes
were pooled, centrifuged (400 × g, 10 min), resuspended
in complete endothelial cell growth medium (ECGM;
PromoCell, Germany), plated in 25 cm2 plastic tissue
culture flasks (Nunc), and incubated at 37 °C in 5 %
CO2. The BUVEC monolayers were fed complete ECGM
one day after isolation and then every 2–3 days there-
after. The purity of BUVEC was at least 97 % and char-
acterized by their typical cobblestone morphology and
by the incorporation assay of Dil-Ac-LDL (dioactecylte-
tramethyl-indocarbocyanine perchlorate acetylated low-
density lipoprotein) as described elsewhere, [54]. The
cells were used for the NEFA experiments after 1–6 pas-
sages in vitro.
BUVEC cultures were fed three times a week with
modified ECGM culture medium: 70 % M199 (Gibco)
with 30 % complete ECGM supplemented with epithelial
and endothelial growth factors, heparin (all from Promo-
Cell), 2 mM glutamine, 2 % FCS, 100 U/ml penicillin,
and 100 μg/ml streptomycin sulfate (HyClone, Thermo
Scientific, USA). The cells were maintained at 37 °C in a
5 % CO2 atmosphere.
Intracellular calcium measurement
For the NEFA experiments, BUVEC monolayers were
trypsinized with 0.25 % trypsin/EDTA (Gibco) from
plastic tissue culture plates (Life Technologies, USA),
and 5 × 106 cells/ml were suspended and incubated for
30 min at 37 °C in HEPES-buffered saline (HBS) buffer
(concentrations in mM: 150 NaCl, 5 KCl, 1 CaCl2, 1
MgCl2, 20 HEPES, 5 glucose, pH 7.4), supplemented
with 10 μM Fura-2-AM and 0.02 % Pluronic F-127 (Invi-
trogen, Molecular Probes, USA). The unincorporated
dye was removed twice with HBS buffer washes. The
cells (250,000 cells/ml) were stored in HBS at 4 °C, and
then prewarmed for 5 min at 37 °C. Fluorescence inten-
sities were detected every 0.2 s at 509 nm emission and
340/380 nm dual-wavelength excitation in an LS55 spec-
trofluorometer (PerkinElmer Life Science, USA). The
time course of FURA-2/AM in BUVECs was recorded
as the ratio of the fluorescent signals without stimulus
for 50 s and during exposure to each fatty acid for 100 s.
The area under curve (AUC) of calcium flux was calcu-
lated for the 100 s of NEFA exposure after background
subtraction. The slopes of the increase in the calcium sig-
nal caused by fatty acids were calculated with a linear re-
gression adjusted to the first 8 s of the fluorescent signal
ratio (340/380) under basal and BAPTA-AM conditions.
NO measurement
Cells were trypsinized, as described above, seeded in a
96-well plate at a density of 20,000 cell/well, and cul-
tured with 100 μl of ECGM-supplemented medium
(PromoCell). On day 3, the cells were washed gently
once with HBS and incubated for 20 min at room
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temperature with 5 μM DAF-FM and 0.02 % pluronic
acid (Invitrogen, Molecular Probes, USA). The unincor-
porated dye was removed by washing once with HBS.
When the cells were pretreated before fatty acid expos-
ure, they were incubated for 15 min. The cells were then
incubated with different NEFAs in the absence and pres-
ence of different treatments for 5 min at 37 °C. The
DAF-FM signals were then detected with a fluorescence
multiplate reader (Varioskan®, Thermo Scientific) at
480 nm excitation/520 nm emission with light detection
for 800 ms.
To assess the roles of intracellular and extracellular
calcium in the calcium flux and NO production in
BUVECs, the cells were incubated for 30 min with
50 μM BAPTA/AM at 37 °C, then washed, and main-
tained in HBS. For the EGTA treatment, the cells were
treated with HEPES-buffered saline without calcium,
and EGTA (0.3 mM) was added just before measure-
ment [55].
Immunoblotting
BUVECs were lysed with a previously described method
[53], and 50 μg of total protein was loaded onto a 12 %
polyacrylamide gel and transferred to a nitrocellulose
membrane at 100 mA for 1 h. The nitrocellulose mem-
brane was incubated with blocking buffer for 1 h, and
probed overnight at 4 °C with 0.001 μg/μl anti-human-
GPR40 antiserum prepared in a rabbit (Abcam, USA).
The membrane was washed three times in Tris-buffered
saline and then exposed to 1:5000 anti-rabbit-IgG anti-
body conjugated with horseradish peroxidase (Cell Sig-
naling) for 1 h at room temperature. Blocked antibody
solutions were prepared with 1 % fat-free milk phosphate-
buffered saline (PBS)–Tween 0.1 % (PBST), and signals
were detected with an enhanced chemiluminescence
system.
Indirect immunofluorescence
Cells were grown on 12 mm glass coverslips, fixed with
4 % paraformaldehyde (Merck), permeabilized with
100 μM digitonin (Sigma-Aldrich). They were incubated
with 0.010 μg/μl anti-GPR40 antiserum (Abcam, USA)
overnight at room temperature, and then with 0.4 μg/μl
Alexa-Fluor-488-conjugated anti-rabbit IgG antibody
(Calbiochem, USA) for 1 h at room temperature. The
anti-GPR40 antiserum was raised against the human epi-
tope, but this particular peptide region is conserved in
bovine species, as the predictive sequence indicates [13].
This antibody has been used successfully in our labora-
tory, as described elsewhere [14]. The blocking and anti-
body solutions were prepared with 1 % BSA–PBST
(Sigma-Aldrich). Cell nuclei were stained with 0.1 μg/μl
propidium iodide (Invitrogen, Molecular Probes, USA) di-
luted in PBS. The images were obtained on a Fluoview
SV1000® confocal microscope (Olympus) (Centre of Sci-
entific Studies, Valdivia, Chile) equipped with a digital
camera.
Cell death assay
Cells were seeded in 96-well plates at 20,000 cells/ml,
and on day 3, were washed gently with HBS before ex-
posure to NEFAs for 15 min at 37 °C. As the positive
control for cell death, cells were treated with 0.2 % Tri-
ton X-100 diluted in HBS at 37 °C for 15 min. BUVECs
were treated with different single NEFAs (300 μM LA,
PA, OA, MA, or SA), Triton X-100, or 1 % vehicle
(DMSO or ethanol). The cells were then incubated with
5 μM propidium iodide (Molecular Probes, Invitrogen)
in HBS for 15 min. The propidium iodide signals were de-
tected with a fluorescence multiplate reader (Varioskan®,
Thermo Scientific) at 530 nm excitation/620 nm emission.
NEFA effects on adhesion molecule expression in BUVECs
To determine the effects of NEFAs on the expression of
adhesion molecules, confluent BUVEC monolayers were
treated with 300 μM MA or vehicle (0.1 % ethanol), or
300 μM OA, 300 μM LA, or vehicle (0.1 % DMSO) for
3 h and their total RNA was then isolated. In another
set of experiments, BUVECs were preincubated with
10 μM GW1100 or 4 μM U73122 for 30 min before LA
treatment.
RNA isolation and RT–PCR analysis
Total RNA was isolated from BUVECs with the E.Z.N.A
Total RNA Kit® (Omega Bio-Tek, Norcross, GA, USA),
according to the manufacturer’s instructions. The sam-
ples were treated with ribonuclease-free deoxyribonucle-
ase I (Turbo DNA-free Kit, Ambion, UK) to remove any
genomic DNA, and the RNA was quantified with a
NanoDrop 2000 spectrophotometer (Thermo Fisher Sci-
entific). For cDNA synthesis, 200 ng of RNA was reverse
transcribed in the presence or absence of M-MLV re-
verse transcriptase (Promega). The PCR reaction was
performed with Maxima SYBR Green/ROX qPCR Mas-
ter Mix and 1 μL of cDNA. The primers for ICAM-1
and IL-8 used in this study were designed previously
[15, 53]. SDHA cDNA was also amplified as the house-
keeping control [56].
Statistical analysis
The results are illustrated in bar graphs as the means ±
SEM of at least four independent experiments. Student’s
t test or one-way analysis of variance and Dunnett’s mul-
tiple comparison test were performed with a significance
level of 5 %, using GraphPad Prism for Mac OS X (ver.
5.0; GraphPad Software, USA).
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Additional files
Additional file 1: NEFA treatment did not affect BUVEC cell
viability. Cells were incubated for 15 min in the presence of HBS alone
(basal), 0.3 mM EGTA (in HBS), solvent (DMSO or ethanol), 300 μM of
each fatty acid or 300 μM fatty acid plus EGTA. In other experimental set,
cells also were incubated for 30 min with 50 μM BAPTA-AM in HBS and
then exposed to each fatty acid for 15 min. Afterwards, the cells were
exposed to propidium iodide in HBS for 15 min. The signals of the
incorporated propidium iodide were detected with a fluorescence
multiplate reader in arbitrary units of fluorescence. Each bar represents
the mean ± SEM of at least three independent experiments. Myristic acid
(MA), palmitic acid (PA), stearic acid (SA), linoleic acid (LA), oleic acid (OA).
**p < 0.05 compared with basal. (PPT 128 kb)
Additional file 2: Effects of BAPTA and EGTA treatments on the
slope of the Fura-2/AM signal in cells treated with myristic acid
(MA) palmitic acid (PA), stearic acid (SA), linoleic acid (LA), or oleic
acid (OA). Data are means ± standard deviations; NS: not significant.
(DOC 29 kb)
Additional file 3: Effect of GW110 on the increase in the area under
curve of Fura-2/AM, induced with myristic acid (MA) palmitic acid
(PA), stearic acid (SA), linoleic acid (LA), or oleic acid (OA). Data are
means ± standard deviations; NS: not significant. (DOC 33 kb)
Abbreviations
BAPTA-AM: 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
tetrakis(acetoxymethyl ester); BSA: bovine serum albumin; BUVEC: bovine
umbilical vein endothelial cells; DMSO: dimethyl sulfoxide; EGTA: ethylene
glycol-bis-(2-aminoethyl)-N,N,N', N'- tetraacetic acid; eNOS: endothelial nitric
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